
Photo: Depositphotos
Jul 2, 2025, 08:21
NCI Center for Cancer Research – cfDNA Offers Non-Invasive Approach to Understand and Treat SCLC without Tumor Biopsies
NCI Center for Cancer Research posted on LinkedIn:
“Profiling circulating cell-free DNA (cfDNA) has become a fundamental practice in cancer medicine: cfDNA can be obtained through plasma samples. The use of plasma to guide therapy is particularly of interest for use in analyzing small cell lung cancer (SCLC), due to the aggressive nature of this cancer, which makes obtaining tumor biopsies exceedingly challenging.
A study by CCR researchers analyzed cfDNA in plasma samples of 20 patients and found that the cfNDA in the blood matches the genetic information from their tumors, even revealing important changes and resistance mechanisms that the tissue biopsies missed. Their findings suggest that cfDNA can provide a detailed, non-invasive way to understand and treat SCLC without the need for tumor biopsies.
Image: Distributions of single nucleotide variants in cfDNA samples and tumor samples. Of note, the two sample types produced matching information.”
Title: Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumor
Authors: Nobuyuki Takahashi, Lorinc Pongor, Shivam P. Agrawal, Mariya Shtumpf, Ankita Gurjar, Vinodh N. Rajapakse, Ahmad Shafiei, Christopher W. Schultz, Sehyun Kim, Diana Roame, Paula Carter, Rasa Vilimas, Samantha Nichols, Parth Desai, William Douglas Figg Sr., Mohammad Bagheri, Vladimir B. Teif, Anish Thomas
Read The Full Article at Genome Medicine.
More posts featuring SCLC.
Ahmad Shafiei
Anish Thomas
Ankita Gurjar
cancer
Christopher W. Schultz
Diana Roame
Lorinc Pongor
Mariya Shtumpf
Mohammad Bagheri
NCI Center for Cancer Research
Nobuyuki Takahashi
OncoDaily
Oncology
Parth Desai
Paula Carter
Rasa Vilimas
Samantha Nichols
SCLC
Sehyun Kim
Shivam P. Agrawal
small cell lung cancer
Vinodh N. Rajapakse
Vladimir B. Teif
William Douglas Figg Sr.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 2, 2025, 13:19
Jul 2, 2025, 11:38